OBJECTIVES - The aim of this study was to evaluate the expression of MIB-1, BCL-2, VEGFR3, and CD31 and their associations with long-term survival in patients with renal cell cancer (RCC).
PATIENTS AND METHODS - This study consisted of 224 RCC patients who underwent radical nephrectomy from 1985 to 1995.